Skip to content

Drug interactions

Berotralstat + Dipyridamole

Severity: Minor

Berotralstat and Dipyridamole: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dipyridamole inhibits BCRP and may raise berotralstat exposure. This could increase berotralstat adverse effects such as gastrointestinal upset.

What this interaction means in plain words

Berotralstat and Dipyridamole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Berotralstat belongs to Miscellaneous; Dipyridamole belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of BCRP-mediated efflux by dipyridamole may increase berotralstat absorption and exposure.

What to do

Monitor for berotralstat adverse effects, particularly gastrointestinal symptoms and QT-related symptoms at higher exposure.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Berotralstat and Dipyridamole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Berotralstat with Dipyridamole?

MediHelp rates the interaction as minor. Berotralstat and Dipyridamole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dipyridamole inhibits BCRP and may raise berotralstat exposure. This could increase berotralstat adverse effects such as gastrointestinal upset.

How serious is the interaction between Berotralstat and Dipyridamole?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for berotralstat adverse effects, particularly gastrointestinal symptoms and QT-related symptoms at higher exposure.

What other medicines interact with Dipyridamole?

MediHelp also lists interactions of Dipyridamole with, for example, Riociguat, Adenosine, Betrixaban. The full list is on the Dipyridamole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in